Second-Line Switch to Dolutegravir for Treatment of HIV Infection.
Ombajo LA, Penner J, Nkuranga J, Mecha J, Mburu M, Odhiambo C, Ndinya F, Aksam R, Njenga R, Wahome S, Muiruri P, Eshiwani S, Kimani M, Ngugi C, Pozniak A.
Ombajo LA, et al. Among authors: mecha j.
N Engl J Med. 2023 Jun 22;388(25):2349-2359. doi: 10.1056/NEJMoa2210005.
N Engl J Med. 2023.
PMID: 37342923
Clinical Trial.